Trial intelligence / Profile preview

Hypertonic saline versus isotonic saline in young children with cystic fibrosis

2015-004143-39Phase 3Completed

Sponsor
Erasmus MC
Start
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in cystic fibrosis (CF) comparing Hypertonic saline with Isotonic saline control (2 arms). Primary endpoint: PRAGMA-CF total percent disease at 48 weeks. Started Dec 2015; status: completed.

02

Drugs

hypertonic salineisotonic saline
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on 2015-004143-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-004143-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call